See more : Royce Global Value Trust, Inc. (RGT) Income Statement Analysis – Financial Results
Complete financial analysis of SeaStar Medical Holding Corporation (ICU) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of SeaStar Medical Holding Corporation, a leading company in the Biotechnology industry within the Healthcare sector.
You may be interested
- Mensch und Maschine Software SE (MUM.DE) Income Statement Analysis – Financial Results
- Huadian Power International Corporation Limited (600027.SS) Income Statement Analysis – Financial Results
- BWX Limited (BWX.AX) Income Statement Analysis – Financial Results
- Nippon Carbon Co., Ltd. (5302.T) Income Statement Analysis – Financial Results
- Easun Capital Markets Limited (EASUN.BO) Income Statement Analysis – Financial Results
SeaStar Medical Holding Corporation (ICU)
About SeaStar Medical Holding Corporation
SeaStar Medical Holding Corporation, a medical device company, focuses on providing novel solutions and services to treat hyperinflammation and cytokine storm in critically ill patients. The company is developing and commercializing extracorporeal therapies that target the effector cells that drive systemic inflammation, causing direct tissue damage and secreting a range of pro-inflammatory cytokines that initiate and propagate imbalanced immune responses. It is developing products in various therapeutic areas, including pediatric and adult acute kidney injury on CRRT; cardiorenal syndrome in congestive heart failure with and without LVAD; myocardial stunning in end stage renal disease; and hepatorenal syndrome. The company is based in Denver, Colorado.
| Metric | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 |
| Cost of Revenue | 0.00 | 0.00 | 0.00 | 0.00 |
| Gross Profit | 0.00 | 0.00 | 0.00 | 0.00 |
| Gross Profit Ratio | 0.00% | 0.00% | 0.00% | 0.00% |
| Research & Development | 5.97M | 2.82M | 2.77M | 4.03M |
| General & Administrative | 8.01M | 6.60M | 1.68M | 2.43M |
| Selling & Marketing | 32.00K | 0.00 | 0.00 | 0.00 |
| SG&A | 8.04M | 6.60M | 1.68M | 2.43M |
| Other Expenses | 200.00K | 0.00 | 91.00K | 84.00K |
| Operating Expenses | 14.21M | 11.61M | 4.45M | 6.45M |
| Cost & Expenses | 14.21M | 11.61M | 4.45M | 6.45M |
| Interest Income | 0.00 | 630.00 | 212.00 | 3.31K |
| Interest Expense | 1.08M | 630.00K | 212.00K | 3.31M |
| Depreciation & Amortization | 14.01M | 11.61M | 4.45M | 6.45M |
| EBITDA | -11.14M | -11.61M | 0.00 | 0.00 |
| EBITDA Ratio | 0.00% | 0.00% | 0.00% | 0.00% |
| Operating Income | -14.21M | -11.61M | -4.45M | -6.45M |
| Operating Income Ratio | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Other Income/Expenses | -12.02M | -11.40M | -148.00K | 3.19M |
| Income Before Tax | -26.23M | -23.01M | -4.60M | -3.27M |
| Income Before Tax Ratio | 0.00% | 0.00% | 0.00% | 0.00% |
| Income Tax Expense | 0.00 | 1.00K | -1.00K | 9.00K |
| Net Income | -26.23M | -23.01M | -4.60M | -3.28M |
| Net Income Ratio | 0.00% | 0.00% | 0.00% | 0.00% |
| EPS | -30.29 | -70.16 | -15.90 | -27.15 |
| EPS Diluted | -30.26 | -70.07 | -15.87 | -27.15 |
| Weighted Avg Shares Out | 866.00K | 328.00K | 289.00K | 120.67K |
| Weighted Avg Shares Out (Dil) | 866.81K | 328.45K | 289.55K | 120.67K |
The Schall Law Firm Is Seeking Investors To Join A Case Against SeaStar Medical Holding Corporation For Securities Fraud
LOS ANGELES, CA / ACCESSWIRE / September 4, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against SeaStar Medical Holding Corporation ("SeaStar" or "the Company") (NASDAQ:ICU) for violations of...
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of September 6, 2024 in SeaStar Medical Lawsuit - ICU
NEW YORK, NY / ACCESSWIRE / September 4, 2024 / If you suffered a loss on your SeaStar Medical Holding Corporation (NASDAQ:ICU) investment and want to learn about a potential recovery under the federal securities laws, follow the link below...
ICU; ICUCW INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Seastar Medical Holding Corp. Stockholders with Losses Have Opportunity to Lead Class Action Lawsuit!
NEW YORK, NY / ACCESSWIRE / September 4, 2024 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Seastar Medical Holding Corp. ("Seastar" or "the Company") (NASDAQ:...
SeaStar Medical Strengthens Financial Position with Elimination of All Long-Term Debt
DENVER, Sept. 04, 2024 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU) (SeaStar Medical), a commercial-stage medical device company developing proprietary solutions to reduce the consequences of hyperinflammation on vital organs, reports that it has now retired all long-term...
Shareholders that lost money on SeaStar Medical Holding Corporation (ICU) should contact Levi & Korsinsky about pending Class Action - ICU
NEW YORK, NY / ACCESSWIRE / September 4, 2024 / If you suffered a loss on your SeaStar Medical Holding Corporation (NASDAQ:ICU) investment and want to learn about a potential recovery under the federal securities laws, follow the link below...
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of September 6, 2024 in SeaStar Medical Lawsuit – ICU
NEW YORK, NY / ACCESSWIRE / September 3, 2024 / If you suffered a loss on your SeaStar Medical Holding Corporation (NASDAQ:ICU) investment and want to learn about a potential recovery under the federal securities laws, follow the link below...
SeaStar Medical Holding Corporation Sued for Securities Law Violations – Investors Should Contact Levi & Korsinsky for More Information – ICU
NEW YORK, NY / ACCESSWIRE / September 3, 2024 / If you suffered a loss on your SeaStar Medical Holding Corporation (NASDAQ:ICU) investment and want to learn about a potential recovery under the federal securities laws, follow the link below...
ICU; ICUCW SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Seastar Medical Holding Corp. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!
NEW YORK, NY / ACCESSWIRE / September 3, 2024 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Seastar Medical Holding Corp. ("Seastar" or "the Company") (NASDAQ:...
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of September 6, 2024 in SeaStar Medical Holding Corporation Lawsuit - ICU
NEW YORK, NY / ACCESSWIRE / September 3, 2024 / If you suffered a loss on your SeaStar Medical Holding Corporation (NASDAQ:ICU) investment and want to learn about a potential recovery under the federal securities laws, follow the link below...
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in SeaStar Medical Holding Corporation of Class Action Lawsuit and Upcoming Deadlines - ICU
NEW YORK , Sept. 3, 2024 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against SeaStar Medical Holding Corporation ("SeaStar" or the "Company") (NASDAQ: ICU) and certain officers.
Source: https://incomestatements.info
Category: Stock Reports